AVITA Medical, Inc. (RCEL) Total Liabilities (2018 - 2026)

AVITA Medical (RCEL) has reported Total Liabilities for 9 consecutive years, with $75.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 6.53% year-over-year to $75.6 million; the trailing twelve-month figure through Jun 2026 stood at $75.6 million (up 6.53% YoY), and the FY2025 full-year result was $73.0 million, down 2.57% from the prior year.
• Total Liabilities rose to $75.6 million in Q2 2026 per RCEL's latest filing, from $73.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $75.6 million in Q2 2026 and bottomed at $8.7 million in Q1 2022.
• Historically, Total Liabilities has averaged $46.4 million across 5 years, with a median of $63.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities slipped 5.12% in 2022, then jumped 377.3% in 2023.
• Over 5 years, Total Liabilities stood at $13.0 million in 2022, then surged by 377.3% to $61.9 million in 2023, then rose by 21.13% to $75.0 million in 2024, then slipped by 2.57% to $73.0 million in 2025, then grew by 3.52% to $75.6 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $75.6 million, $73.0 million, and $70.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.